The US company, which is aiming to bring back extinct species, says that it expects its first woolly mammoth calves will be born in the next three years.

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

The life-sized woolly mammoth fossil sitting inside the Natural History Society of Maryland has the wow factor for those who ...

But Ben Lamm, CEO and founder of Colossal Biosciences, has said he's 'positive' the first woolly mammoth calves will be born in the next few years. 'Our recent successes in creating the ...

After this week’s bout of bitter cold following several snowfalls, many folks are hoping Woolly will go against her trend and ...

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodiversity and combat climate change by creating cold ...

No, this isn’t a new Jurassic Park plot: A real-life woolly mammoth could be on Earth by the decade’s end. Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Colossal Biosciences, which is known for its plans to revive extinct animals, says that ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.